Current Research Studies

Cancer – NANT 2017-01: Phase I Study of 131I-MIBG with Dinutuximab for Relapsed/Refractory Neuroblastoma

Condition or Therapy:



Cancer and blood disorders

What is the goal of this study?

The goal of this study is to determine how the combination of 131I-MIBG works with dinutuximab in patients with neuroblastoma.

Who can join the study?

This study may be a good fit for children and young adults who

  • Are 1 to 30 years old and
  • Have been diagnosed with neuroblastoma

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Navin Pinto